• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

EL Camino Health Offers Personalized Chatbot to Patients with COPD

Share:

February 12, 2020

Highlights on this story:
  • El Camino Health is now offering personalized virtual health assistant to patients suffering from COPD via Conversa Health partnership designed to improve respiratory care coordination and patient experience.
  • Innovative 2 BREATHE (Be Resilient EAch Time after a Hospital Event) chat program leverages Conversa’s patient engagement platform assigns patients with a respiratory therapist and a pulmonary nurse practitioner for personalized treatment to help patients breathe easier.

Following a successful pilot, El Camino Health’s nationally renowned pulmonary health department is now offering Conversa Health’s personalized virtual health assistant technology to patients with chronic obstructive pulmonary disorder (COPD) as 2 BREATHE Chat program. 2 BREATHE chat program enables patients with COPD, asthma and other respiratory illnesses to be monitored remotely by their care team.

2 BREATHE Chat Initial Pilot Results

COPD and asthma alone affect more than 50 million Americans, and the mortality rate for COPD patients has risen in the last 35 years. El Camino Health’s care team saw immediate and significant improvement in patient outcomes during the initial pilot. COPD Assessment (CAT) scores trended down after the introduction of 2 BREATHE Chat, which regularly “checks in” with patients to collect meaningful health data in real-time.

Additionally, the team reported a high rate of sustained patient engagement (85% regularly used Conversa’s platform). Patients averaged 15 chats during a 90-day program (above average for episodic care engagement rates), with 94% of patients said they were satisfied with the virtual health experience. Patient readmission was significantly reduced and even then, readmissions involved catching issues much earlier than usual, therefore improving overall patient outcomes.

“We looked to Conversa’s high-touch care platform to help us reduce 30-day readmissions and shorten the length of hospital stays for patients suffering from COPD,” said Cheryl Reinking, chief nursing officer of El Camino Health’s hospitals. “The results were so impressive that we decided to move from pilot to a full rollout of offering 2 BREATHE Chat to inpatients and outpatients.”

How The 2 BREATHE Chat Program Works

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Patients enrolled in the 2 BREATHE Chat program receive notifications for their chats via email or SMS text message — whichever you prefer. Patients simply click the link in the notification and their secure, personalized chat will begin immediately. Every patient’s 2 BREATHE Chat experience is personalized based on their specific unique health conditions and concerns that ensure they receive chats that are relevant and meaningful.

In addition, the patient’s 2 BREATHE care team:

– Provides education about their condition

– Reviews all treatments with the patient, such as medicines, oxygen therapy, mucus clearance techniques and infection prevention strategies.

– Provides smoking-cessation counseling, if needed.

– Coordinates follow-up appointments with their doctor.

– Suggests other services and resources that can help, such as the Better Breather’s Club & Support Group, a dietitian or a medical social worker.

– Follows up with regularly using 2 BREATHE Chat to monitor your condition. With 2 BREATHE chat, patients will receive personalized, automated check-in messages on your phone or computer.

Pulmonary Health Program at El Camino Health Background

The Pulmonary Health Program at El Camino Health offers advanced diagnostic and therapeutic modalities, including airway recanalization, bronchoscopic lung volume reduction, clinical trials, confocal endomicroscopy, electromagnetic navigation guided (EMN) bronchoscopy, endobronchial ultrasound (EBUS), transbronchial cryobiopsy, and robotic-assisted bronchoscopy.

Focusing specifically on COPD, the organization recently launched a Chronic Respiratory Disease Program. This Medicare-covered chronic care management service partners with patients to develop a personalized, comprehensive care plan to identify health concerns and goals, track medications, coordinate with healthcare providers and connection to support resources, and provide education and 24/7 access for urgent needs.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Xenex LightStrike Robot Destroys SARS-CoV-2 (Coronavirus) in 2 Minutes;Xenex LightStrike Robot Destroys SARS-CoV-2 (Coronavirus) in 2 Minutes;
  • Bioburden Testing Market Research Report 2020 | Industry Report, Industry Analysis, Key Players, Trends, Revenue, Regional Segmented, Outlook Until 2030Bioburden Testing Market Research Report 2020 | Industry Report, Industry Analysis, Key Players, Trends, Revenue, Regional Segmented, Outlook Until 2030
  • Here are 6 major issues facing healthcare in 2019, according to PwCHere are 6 major issues facing healthcare in 2019, according to PwC
  • Adaptive Child Development App Closes $2M Seed RoundAdaptive Child Development App Closes $2M Seed Round
  • Wireless EEG Headset Zeto Raises $7.3M in Series A FundingWireless EEG Headset Zeto Raises $7.3M in Series A Funding
  • MiNA Therapeutics : Announces Sosei Will Not Exercise Acquisition OptionMiNA Therapeutics : Announces Sosei Will Not Exercise Acquisition Option
  • Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in RevenueSunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in Revenue
  • How Retail Giant Walmart Plans to Disrupt the Healthcare IndustryHow Retail Giant Walmart Plans to Disrupt the Healthcare Industry

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications